Marcain 0.5% with adrenaline (epinephrine) 1:200,000 20mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

marcain 0.5% with adrenaline (epinephrine) 1:200,000 20ml injection vial

aspen pharmacare australia pty ltd - bupivacaine hydrochloride, quantity: 5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 5.28 mg/ml); adrenaline (epinephrine) acid tartrate, quantity: 9.1 microgram/ml (equivalent: adrenaline (epinephrine), qty 5 microgram/ml) - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; sodium metabisulfite; water for injections; hydrochloric acid - indications as at 4 april 2000: marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.

Adrenaline (AstraZeneca) New Zealand - English - Medsafe (Medicines Safety Authority)

adrenaline (astrazeneca)

astrazeneca limited - adrenaline acid tartrate 0.182 mg/ml;   - solution for injection - 1:10000 - active: adrenaline acid tartrate 0.182 mg/ml   excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 10 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 10 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 20 mg (equivalent: noradrenaline (norepinephrine), qty 10 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 6 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 6 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 12 mg (equivalent: noradrenaline (norepinephrine), qty 6 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 5 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 5 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 10 mg (equivalent: noradrenaline (norepinephrine), qty 5 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sumpathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

NORALIN Noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 mL solution for intravenous infusion, vial Australia - English - Department of Health (Therapeutic Goods Administration)

noralin noradrenaline (norepinephrine) (as acid tartrate monohydrate) 3 mg/50 ml solution for intravenous infusion, vial

boucher & muir pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 6 mg (equivalent: noradrenaline (norepinephrine), qty 3 mg) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

ADRENALINE-LINK Australia - English - Department of Health (Therapeutic Goods Administration)

adrenaline-link

link medical products pty ltd t/a link pharmaceuticals - adrenaline acid tartrate -

Marcain 0.25% with adrenaline (epinephrine) 1:400,000 20mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

marcain 0.25% with adrenaline (epinephrine) 1:400,000 20ml injection vial

aspen pharmacare australia pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 4.5 microgram/ml (equivalent: adrenaline (epinephrine), qty 2.5 microgram/ml); bupivacaine hydrochloride, quantity: 2.5 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 2.64 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia; epidural block for surgery, field block (minor and major nerve blocks and infiltration). analgesia; continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. field block (minor nerve block and infiltration). the choice of 4 strengths, 0.125%, 0.25%, 0.375% and 0.5%, makes it possible to vary the degree of motor blockade.

Lignospan Special New Zealand - English - Medsafe (Medicines Safety Authority)

lignospan special

ivoclar vivadent ltd - adrenaline acid tartrate 0.002275%{relative} equivalent to adrenaline 1:80 000;  ;  ; lidocaine hydrochloride monohydrate 2.134%{relative} equivalent to 2.000% w/v anhydrous - solution for injection - active: adrenaline acid tartrate 0.002275%{relative} equivalent to adrenaline 1:80 000     lidocaine hydrochloride monohydrate 2.134%{relative} equivalent to 2.000% w/v anhydrous excipient: potassium metabisulfite sodium chloride sodium edetate sodium hydroxide water for injection

Adrenaline Aguettant 1:10,000 New Zealand - English - Medsafe (Medicines Safety Authority)

adrenaline aguettant 1:10,000

juno pharmaceuticals nz limited - adrenaline acid tartrate 1.1819 mg/ml equivalent to adrenaline 1 mg;   - solution for injection - 1 mg/10ml - active: adrenaline acid tartrate 1.1819 mg/ml equivalent to adrenaline 1 mg   excipient: hydrochloric acid sodium hydroxide water for injection - adjunctive use in the management of cardiac arrest, and anaphylactic shock resulting from reactions to drugs, animal serums, insect stings and other allergens.